Total Return chart NewGLAB Pharma CO.,LTD

Equities

End-of-day quote Korea S.E. Other stock markets 06:00:00 2023-03-08 pm EST			5-day change	1st Jan Change
6,915 ^KRW	-27.44%		-.--%	-.--%

Mar. 04	NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	CI
Feb. 22	NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

2015-12-28

Annual 50 KRW